NCT03000166

Brief Summary

The purpose of the study is to determine the impact of a physical activity intervention on the self-management of fatigue in young adults receiving chemotherapy. Half of the participants will receive an intervention which includes education and resources to set physical activity goals and monitor progress toward goals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 21, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

January 31, 2017

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 16, 2019

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

August 11, 2021

Completed
Last Updated

August 11, 2021

Status Verified

July 1, 2021

Enrollment Period

2.2 years

First QC Date

December 15, 2016

Results QC Date

September 30, 2020

Last Update Submit

July 19, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Self-efficacy for Physical Activity

    Physical Activity Assessment Inventory (Haas \& Northam, 2010) The scale measures confidence to be physically active under various conditions. Scores range from 0=cannot do at all to 100=certain can do.

    Completion of post-study measures (average 15 weeks)

  • Self-regulation of Physical Activity

    Index of Self-Regulation (Yeom et al., 2011) The scale measures self-regulation skills, including processing information, monitoring performance, and taking action to meet goals. Scores range from 1 to 6, with higher scores indicating agreement that the individual has these skills.

    Completion of post-study measures (average 15 weeks)

Secondary Outcomes (2)

  • Steps Per Day

    Completion of post-study measures (average 15 weeks)

  • Fatigue Severity

    Completion of end-of-study measures (average 15 weeks)

Study Arms (2)

Step-Up Intervention Group

EXPERIMENTAL

Participants assigned to the Step-up intervention group will receive a 12-week physical activity intervention which includes components of education, negotiated collaboration to set individual physical activity goals during chemotherapy cycles, and tools for self-monitoring of physical activity.

Behavioral: Step-Up Intervention

Attention Control Group

NO INTERVENTION

Participants assigned to the attention control group will receive usual guidance about maintaining physical activity during chemotherapy from their oncology providers.

Interventions

Intervention group participants will meet with a study facilitator during 5 regularly scheduled visits for chemotherapy. The facilitator will provide education about the benefits of physical activity and strategies to overcome barriers to physical activity, help the participants to set physical activity goals based on ability and preferences, and educate the participant on using a physical activity tracker.

Step-Up Intervention Group

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • have a diagnosis of cancer;
  • are within the first two months of a chemotherapy regimen that will last at least another 3 months;
  • are ambulatory without assistance;
  • have written consent from their physician to participate;
  • have the ability to understand English;
  • have access to a computer and the Internet.

You may not qualify if:

  • symptoms of uncontrolled cardiopulmonary disease, neurological disease
  • delayed wound healing
  • high risk of bone fracture
  • pre-existing peripheral neuropathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Froedtert Hospital

Milwaukee, Wisconsin, 53226, United States

Location

Children's Hospital of Wisconsin

Milwaukee, Wisconsin, 53233, United States

Location

MeSH Terms

Conditions

NeoplasmsMotor Activity

Condition Hierarchy (Ancestors)

Behavior

Results Point of Contact

Title
Jeanne M. Erickson, PhD, RN
Organization
University of Wisconsin-Milwaukee

Study Officials

  • Rachel Schiffman, PhD

    University of Wisconsin, Milwaukee

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 15, 2016

First Posted

December 21, 2016

Study Start

January 31, 2017

Primary Completion

May 1, 2019

Study Completion

July 16, 2019

Last Updated

August 11, 2021

Results First Posted

August 11, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations